PUBLISHER: The Business Research Company | PRODUCT CODE: 1945381
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945381
Injection pens are utilized to administer medication beneath the skin. They offer a more convenient and user-friendly method for delivering injectable medications like insulin, thereby enhancing patient compliance. These pens typically comprise a cartridge, a dosage measurement dial, and a disposable needle, providing a simpler, more accurate, and convenient alternative to using a vial and syringe.
The primary categories of injection pens include disposable and reusable variants. Disposable injection pens feature a non-replaceable prefilled cartridge that is discarded after use. On the other hand, reusable injection pens come with a replaceable cartridge that can be swapped out. Injection pens find application in a range of medical purposes, including diabetes, fertility treatments, osteoporosis, growth hormone therapy, and other therapies. They are employed by various end-users, including home care settings, hospitals, and clinics.
Tariffs are impacting the injection pen market by increasing costs of imported plastic components, precision molding equipment, electronic dose counters, and medical-grade needles. Manufacturers in North America and Europe are most affected due to globalized supply chains, while Asia-Pacific faces cost pressure on export-oriented production. These tariffs are increasing device prices and affecting procurement volumes. However, they are also encouraging local manufacturing, regional component sourcing, and innovation in cost-optimized injection pen designs.
The injection pen market research report is one of a series of new reports from The Business Research Company that provides injection pen market statistics, including injection pen industry global market size, regional shares, competitors with a injection pen market share, detailed injection pen market segments, market trends and opportunities, and any further data you may need to thrive in the injection pen industry. This injection pen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The injection pen market size has grown rapidly in recent years. It will grow from $61.17 billion in 2025 to $67.94 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to increasing prevalence of diabetes and chronic diseases, growth in self-administration therapies, expansion of biologic drug usage, improvements in injection device design, rising patient preference for pen-based delivery.
The injection pen market size is expected to see rapid growth in the next few years. It will grow to $103.59 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to growing demand for home-based drug delivery, rising adoption of smart injection pens, expansion of chronic disease management programs, increasing focus on sustainability in medical devices, advancements in connected drug delivery systems. Major trends in the forecast period include increasing adoption of user-friendly injection devices, rising demand for disposable and prefilled pens, growing integration of dose accuracy and safety features, expansion of reusable and rechargeable injection pens, enhanced focus on patient adherence solutions.
The growth of the injection pen market is being fueled by the increasing prevalence of diseases like diabetes and arthritis. Factors such as the expanding population affected by obesity, sedentary lifestyles, unhealthy dietary habits, and advancing age have contributed to the global rise in diabetes cases. For instance, in April 2025, according to International Diabetes Federation (IDF), a Belgium-based non-governmental, global advocacy organization focused on diabetes care, prevention, and research 589 million adults (20-79 years) are living with diabetes globally, more than the population of the U.S., Canada, Mexico, and the Caribbean combined. The estimated number of adults with diabetes is projected to reach 853 million by 2050. Consequently, the surge in diseases like diabetes and arthritis is expected to be a driving force for the injection pen market.
Major players in the injection pen market are dedicated to introducing innovative products like Wegovy to provide dependable services to customers. Wegovy, administered through an injection pen, is designed for treating patients dealing with obesity and weight loss. In September 2023, Novo Nordisk A/S, a Denmark-based pharmaceutical company, launched Wegovy. This injection pen contains the drug semaglutide, assisting patients in achieving a body weight reduction of approximately 15% when combined with exercise and lifestyle modifications.
In September 2023, Abbott Laboratories, a US-based medical devices company, acquired Bigfoot Biomedical Inc., bolstering its presence in the diabetes care sector with advanced glucose monitoring technology. This strategic move aims to develop user-friendly, cost-effective tools for individuals managing diabetes. Bigfoot Biomedical Inc., headquartered in California, is a medical technology company specializing in smart injection pens.
Major companies operating in the injection pen market are Novo Nordisk A/S, Ypsomed Holding AG, Eli Lilly and Company, Merck KGaA, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Owen Mumford Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Lupin Ltd., Wockhardt Ltd., AptarGroup Inc., Novartis AG, Gerresheimer AG, SHL Medical AG, Boehringer Ingelheim International GmbH, Nemera France SA, Companion Medical Inc., Jiangsu Delfu Medical Devices Co. Ltd., Haselmeier GmbH, Biocon Limited, Becton Dickinson and Company, Mylan N.V., Terumo Corporation, West Pharmaceutical Services Inc., Bespak Europe Ltd., Nipro Corporation, Consort Medical plc, Sandoz Inc., Sulzer Ltd., DuPont de Nemours Inc., Mitsubishi Gas Chemical Company Inc.
North America was the largest region in the injection pen market in 2025. The regions covered in the injection pen market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the injection pen market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The injection pen market consists of sales of disposable injection pens and reusable injection pens. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Injection Pen Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses injection pen market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for injection pen ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The injection pen market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.